Radiology
Combination MMRV Vaccine Associated with Two-Fold Risk of Febrile Seizures Compared with Separate MMR & Varicella Vaccines
June 27, 2010 10:35 pm | by Bio-Medicine.Org | News | CommentsOAKLAND, Calif. , June 28 /- The combination vaccine for measles, mumps, rubella and chickenpox (MMRV) is associated with double the risk of febrile seizures for 1- to 2-year-old children compared with same-day administration of the separate vaccine for MMR (measles, mumps, rubella) and...
Global Pharmaceutical R & D Productivity Declining According to Thomson Reuters, CMR International
June 27, 2010 10:35 pm | by Bio-Medicine.Org | News | CommentsPHILADELPHIA and LONDON , June 28 /- The pharmaceutical industry continues to rely heavily on sales from an aging portfolio of drugs, whilst the proportion of total sales from newer drugs has dropped, according to data released today from the 2010 Pharmaceutical R&D Factbook complied...
BYDUREON(TM) Safety and Tolerability Pooled Summary Data Presented at ADA 2010
June 26, 2010 6:35 am | by Bio-Medicine.Org | News | CommentsORLANDO, Fla. , June 26, 2010 /- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN ), Eli Lilly and Company (NYSE: LLY ) and Alkermes, Inc. (Nasdaq: ALKS ) today announced results of an analysis of pooled safety data from three completed randomized controlled trials that showed the...
Perrigo Company to Present at the Oppenheimer 10th Annual Consumer, Gaming, Lodging and Leisure Conference
June 25, 2010 4:39 pm | by Bio-Medicine.Org | News | CommentsALLEGAN, Mich. , June 25 /- Perrigo Company (Nasdaq: PRGO ; TASE) announced today that Perrigo Chairman and CEO Joseph C. Papa will present at the Oppenheimer 10th Annual Consumer, Gaming, Lodging & Leisure Conference on Tuesday, June 29 , at 3:20 p.m. (ET) at the Four Seasons Hotel...
PartsSource Bestowed 2010 Richard Shatten Civic Distinction Award
June 25, 2010 4:39 pm | by Bio-Medicine.Org | News | CommentsAURORA, Ohio , June 25 /- PartsSource, the world's #1 ebusiness solution provider for replacement medical repair parts for hospital equipment, has been honored with the 2010 Richard Shatten Civic Distinction award for Northeast Ohio . Each year, the Shatten Civic Distinction award...
United Seating & Mobility Launches New Company Website and E-Commerce Store at www.UnitedSeating.com
June 25, 2010 6:34 am | by Bio-Medicine.Org | News | CommentsALBUQUERQUE, N.M. , June 25 /- United Seating & Mobility, the nation's largest privately-owned mobility and rehab equipment supplier, launched a newly redesigned website today at www.UnitedSeating.com . The new site features in-depth information for clients, families, and clinicians,...
Archimedes Pharma Receives CHMP Positive Opinion for PecFent(R) for the Treatment of Breakthrough Cancer Pain
June 25, 2010 5:34 am | by Bio-Medicine.Org | News | CommentsREADING, England , June 25, 2010 /- Archimedes Pharma ("Archimedes"), a leading specialty pharma company, today announced that its lead product, PecFent*, has received a Positive Opinion from the Committee for Human Medicinal Products (CHMP), of the European Medicines Agency (EMA). The...
Soligenix Announces Publication of Positive Data Describing Protection from Mucosal and Systemic Ricin Intoxication by Intradermal RiVaxâ„¢ Administration
June 25, 2010 5:34 am | by Bio-Medicine.Org | News | CommentsPRINCETON, N.J. , June 25 /- Soligenix, Inc. (OTC Bulletin Board: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company, announced today the publication of an article in the June 2010 edition of Vaccine , which describes protection from mucosal and systemic ricin...
IDRI and PATH Enter into Research Collaboration Agreement to Evaluate Novel Adjuvants to Enhance Pandemic Influenza Vaccines
June 24, 2010 10:36 pm | by Bio-Medicine.Org | News | CommentsSEATTLE , June 25 /PRNewswire-USNewswire/ -- Two global health non-profit organizations headquartered in Seattle, Washington , the Infectious Disease Research Institute (IDRI) and PATH, have entered into a Research Collaboration Agreement to evaluate novel adjuvants for their ability to...
Miniature Focus Modules Provide Precise Lens Motion
June 23, 2010 6:53 am | New Scale Technologies, Inc. | Product Releases | CommentsNew Scale Technologies Inc. offers an M3-F focus module for miniature OEM cameras used in handheld products; portable biometric sensors; and medical diagnostic and imaging devices.
Boston Scientific Announces Completion of Refinancing 2011 Debt Maturities With New $3 Billion Bank Credit Facilities
June 23, 2010 4:36 am | by Boston Scientific | News | CommentsNATICK, Mass., June 23 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX) today announced the successful syndication of a new $1 billion, three-year term loan and a new $2 billion, three-year revolving credit
Hanger Orthopedic Group, Inc. Announces Three Acquisitions With Annual Revenues of $14.0 Million
June 22, 2010 5:37 pm | by Bio-Medicine.Org | News | CommentsBETHESDA, Md. , June 22 /- Hanger Orthopedic Group, Inc. (NYSE: HGR ) announced that it continues to expand its geographic presence with  the acquisition of Dynamic Orthotics and Prosthetics of Texas , Nebraska Orthotic and Prosthetic Services, and Spectrum Prosthetics and Orthotics...
TheraQuest Unveils New Pain Management Product Pipeline
June 22, 2010 5:37 pm | by Bio-Medicine.Org | News | CommentsBLUE BELL, Pa. , June 22 /- TheraQuest Biosciences, Inc., a clinical stage pain management company today unveiled its analgesic product pipeline. TheraQuest also announced the launch of its new corporate website at http://www.theraquestinc.com . Najib Babul, PharmD, President and Chief...
Hospira Receives FDA Approval for Meropenem for Injection, USP (I.V.)
June 22, 2010 5:37 pm | by Bio-Medicine.Org | News | CommentsLAKE FOREST, Ill. , June 22 /- Hospira, Inc. (NYSE: HSP ), the world leader in generic injectable pharmaceuticals, today announced it has received U.S. Food and Drug Administration (FDA) approval for meropenem for injection, USP (I.V.) 500 mg and 1 g vials. The medication, a...
Tolera Therapeutics Granted Orphan Drug Designation for Treatment of Type 1 diabetes mellitus
June 22, 2010 5:37 pm | by Bio-Medicine.Org | News | CommentsKALAMAZOO, Mich. , June 22 /- Tolera Therapeutics, Inc., was granted orphan drug status by the United States Food and Drug Administration (FDA) for TOL101 (anti-TCR murine monoclonal antibody, type IgM), for treatment of recent onset immune-mediated Type 1 diabetes mellitus (T1DM)....
Rochester Medical Corporation Honored by Premier Healthcare Alliance for Exceptional Supplier Performance
June 22, 2010 5:36 pm | by Bio-Medicine.Org | News | CommentsSTEWARTVILLE, Minn. , June 22 /- Rochester Medical Corporation (Nasdaq: ROCM ) today announced that it is a winner of the fifth annual Pinnacle Award, presented by the Premier healthcare alliance. Premier contracts with more than 800 suppliers and Rochester Medical is one of 38 contracted...
Anthem Healthcare Intelligence Teams with Oracle to Offer Healthcare Analytic Applications
June 22, 2010 5:36 pm | by Bio-Medicine.Org | News | CommentsLAS VEGAS , June 22 /- Anthem Healthcare Intelligence, Inc. is pleased to announce that they are working with Oracle to provide business intelligence and performance management applications. Anthem will offer its provider specific analytic applications on Oracle's new Enterprise...
ISYS® Search Software Wins Key Enterprise Search Contract With UNAIDS
June 22, 2010 2:35 am | by RealWire | News | CommentsISYS and Partner Raytion Selected to Provide UNAIDS With Enterprise-Wide Information Access SolutionLONDON, 22 June, 2010 - ISYS® Search Software (http://www.isys-search.com), a global supplier of enterprise search solutions for information access, management and reuse, today...
Former Medtronic executive gets top spot at Colorado spine firm
June 21, 2010 10:36 am | by Mass Device | News | CommentsMedtronic Inc.'s former chief operating officer Michael DeMane joins spinal surgery device company Lanx Inc. as chairman and CEO. By Thomas Lee Michael DeMane joined Lanx Inc. as chairman and CEO. The former chief operating officer at Medtronic Inc. (NYSE:MDT) was once...
How to become a salesperson of influence
June 21, 2010 9:35 am | by Mass Device | News | CommentsTen tips to help medical device salespeople become influential advisors to their hospital and physician customers. The other day I spoke to a sales trainer, who was a reference for a candidate. He talked about the difference between being a "pleaser" and an "adviser" to customers. The...
Sinovac Schedules 2010 Annual Meeting of Shareholders
June 18, 2010 8:37 am | by Bio-Medicine.Org | News | CommentsBEIJING , June 18 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (Nasdaq: SVA), a leading developer and provider of vaccines in China , announced today that it will hold its 2010 Annual Meeting of Shareholders on Thursday, July 15, 2010 at 9:00 a.m. Beijing Time. The meeting will be held...
Naviscan Positron Emission Mammography Technology Highlighted at the Society of Nuclear Medicine Annual Meeting
June 18, 2010 8:37 am | by Bio-Medicine.Org | News | CommentsSAN DIEGO , June 18 /- Naviscan's Positron Emission Mammography (PEM) technology was the focus of several presentations and discussions at the Society of Nuclear Medicine Annual Meeting in Salt Lake City . The focus represents a growing interest and validation of how PEM can play an...
ProUroCare Medical Secures $885,000 in Financing
June 17, 2010 6:35 am | by Bio-Medicine.Org | News | CommentsMINNEAPOLIS , June 17 /- ProUroCare Medical, Inc. (OTC Bulletin Board: PUMD), a provider of proprietary imaging products, today announced that it has closed on a $885,000 private placement of debt financing. Â The funding was provided by a small group of existing investors closely...
Renhuang Wins Bid to Supply All-Natural Products to Guangzhou Military District
June 17, 2010 6:35 am | by Bio-Medicine.Org | News | CommentsHARBIN, China , June 17 /PRNewswire-Asia-FirstCall/ -- Renhuang Pharmaceuticals, Inc. (Pink Sheets: RHGP) ("Renhuang" or the "Company"), a developer, manufacturer and distributor of botanical products, bio-pharmaceuticals and traditional Chinese medicines ("TCM"), today announced that on...
Regado Biosciences to Present at the 2010 Wells Fargo Healthcare Conference on June 24, 2010 in Boston, Massachusetts
June 17, 2010 6:34 am | by Bio-Medicine.Org | News | CommentsBASKING RIDGE, N.J. , June 17 /- Regado Biosciences, a privately held company leading the development of antithrombotic aptamers with active control agents, announced that David J. Mazzo , PhD, President and CEO, will be presenting at the 2010 Wells Fargo Healthcare Conference at the...
